Andrew Karter to Managed Care Programs
This is a "connection" page, showing publications Andrew Karter has written about Managed Care Programs.
Connection Strength
1.583
-
Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population. Int J Epidemiol. 2009 Feb; 38(1):38-47.
Score: 0.264
-
Effect of cost-sharing changes on self-monitoring of blood glucose. Am J Manag Care. 2007 Jul; 13(7):408-16.
Score: 0.252
-
The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care. 2002 Feb; 25(2):386-9.
Score: 0.173
-
High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and Management of Diabetes Mellitus (SUPREME-DM) network. J Diabetes Complications. 2017 May; 31(5):869-873.
Score: 0.123
-
Is the physical functioning of older adults with diabetes associated with the processes and outcomes of care? Evidence from Translating Research Into Action for Diabetes (TRIAD). Diabet Med. 2012 Sep; 29(9):e321-5.
Score: 0.090
-
Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study. J Gen Intern Med. 2011 May; 26(5):505-11.
Score: 0.080
-
Predictors of sustained walking among diabetes patients in managed care: the Translating Research into Action for Diabetes (TRIAD) study. J Gen Intern Med. 2008 Aug; 23(8):1194-9.
Score: 0.067
-
Agreement between self-reports and medical records was only fair in a cross-sectional study of performance of annual eye examinations among adults with diabetes in managed care. Med Care. 2007 Sep; 45(9):876-83.
Score: 0.064
-
Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study. Am J Public Health. 2008 Feb; 98(2):365-70.
Score: 0.063
-
The association between clinical care strategies and the attenuation of racial/ethnic disparities in diabetes care: the Translating Research Into Action for Diabetes (TRIAD) Study. Med Care. 2006 Dec; 44(12):1121-8.
Score: 0.061
-
Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2005 Dec; 28(12):2864-70.
Score: 0.056
-
Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care. 2004 Feb; 42(2):110-5.
Score: 0.050
-
Health behaviors and quality of care among Latinos with diabetes in managed care. Am J Public Health. 2003 Oct; 93(10):1694-8.
Score: 0.049
-
Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2003 Aug; 26(8):2294-9.
Score: 0.048
-
Temporal trends in recording of diabetes on death certificates: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care. 2011 Jul; 34(7):1529-33.
Score: 0.021
-
Provider factors and patient-reported healthcare discrimination in the Diabetes Study of California (DISTANCE). Patient Educ Couns. 2011 Dec; 85(3):e216-24.
Score: 0.021
-
Correlates of depression among people with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study. Prim Care Diabetes. 2010 Dec; 4(4):215-22.
Score: 0.020
-
Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiol Drug Saf. 2010 Jul; 19(7):715-21.
Score: 0.019
-
Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009 Apr; 47(4):395-402.
Score: 0.018
-
Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008 May; 23(5):588-94.
Score: 0.017
-
Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care. 2007 Jul; 30(7):1736-41.
Score: 0.016
-
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med. 2004 Jun; 19(6):669-75.
Score: 0.013